GlaucomaCME
VIDEOCMEABO MOC

Improving Compliance Through Sustained-release Delivery Systems for Glaucoma Management

Author(s)/Faculty: Inder Paul Singh, MD; Nathan M. Radcliffe, MD; Thomas W. Samuelson, MD
Release Date: 7/12/2021Expiration Date: 7/11/2022
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 0.75
Content Type: VideoProvider:
Despite the effectiveness of available anti-glaucoma medications, compliance continues to be problematic in patients with glaucoma. Sustained release (SR) platforms for anti-glaucoma medications may help address this problem, and several systems are under development, one is newly approved, and a few more may be commercially available within the next few years. Thus, ophthalmologists must keep apprised of the safety and efficacy of these SR systems so that they can apply this evidence to practice as agents become available for use. In this CME activity, the limitations of topical anti-glaucoma medications in terms of patient compliance and adherence to prescribed regimens are described, as well as a review of the emerging SR formulations of anti-glaucoma medications, including their mechanism of action, efficacy, safety, and potential for improving adherence to therapy.